Michael Stek

Statistics

Publications

Citations

698

H-Index

Active since

1974

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Radboud University Nijmegen

Amsterdam UMC Location University of Amsterdam

Radboud University Medical Center

HIV Netherlands Australia Thailand Research Collaboration

Michael Stek is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, antiretroviral therapy, and infectious diseases.

Publications per year

1974–2010

Publications

Precision and Discriminatory Ability of Calcaneal Bone Assessment Technologies

Susan L. Greenspan, Mary Bouxsein, Mary E. Melton et al. · Journal of Bone and Mineral Research · 1997 · 192 citations

Medicine, Orthopaedic Surgery, Radiology +17

Experience of Healthcare Workers Taking Postexposure Prophylaxis After Occupational HIV Exposures: Findings of the HIV Postexposure Prophylaxis Registry

David J. Weber, Susan A. Wang, Adelisa L. Panlilio et al. · Infection Control and Hospital Epidemiology · 2000 · 113 citations

Public Health, Infectious Disease Control, Hiv Control +12

Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir

Mark Boyd, Preeyaporn Srasuebkul, Kiat Ruxrungtham et al. · Pharmacogenetics and Genomics · 2006 · 64 citations

Medicine, Infectious Diseases, Pharmacology +16

The influence of efavirenz on the pharmacokinetics of a twice‐daily combination of indinavir and low‐dose ritonavir in healthy Volunteers

Rob E. Aarnoutse, Karin Grintjes, Denise Telgt et al. · Clinical Pharmacology & Therapeutics · 2002 · 61 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load

Juan A. Arnaiz, Josep Mallolas, Daniel Podzamczer et al. · AIDS · 2003 · 61 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

1–5 of 14